ATE253913T1 - Anästhetikum - Google Patents
AnästhetikumInfo
- Publication number
- ATE253913T1 ATE253913T1 AT98954639T AT98954639T ATE253913T1 AT E253913 T1 ATE253913 T1 AT E253913T1 AT 98954639 T AT98954639 T AT 98954639T AT 98954639 T AT98954639 T AT 98954639T AT E253913 T1 ATE253913 T1 AT E253913T1
- Authority
- AT
- Austria
- Prior art keywords
- saccharide
- amount
- additional non
- anesthetic agent
- anesthetic
- Prior art date
Links
- 230000003444 anaesthetic effect Effects 0.000 title 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 4
- 210000001175 cerebrospinal fluid Anatomy 0.000 abstract 2
- 239000003193 general anesthetic agent Substances 0.000 abstract 2
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 229960003150 bupivacaine Drugs 0.000 abstract 1
- LEBVLXFERQHONN-INIZCTEOSA-N levobupivacaine Chemical compound CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-INIZCTEOSA-N 0.000 abstract 1
- 229960004288 levobupivacaine Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Anesthesiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9724506.2A GB9724506D0 (en) | 1997-11-19 | 1997-11-19 | Levobupivacaine and its use |
| GBGB9818109.2A GB9818109D0 (en) | 1998-08-19 | 1998-08-19 | Anaesthetic Formulation |
| PCT/GB1998/003479 WO1999025349A1 (en) | 1997-11-19 | 1998-11-19 | Anaesthetic formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE253913T1 true ATE253913T1 (de) | 2003-11-15 |
Family
ID=26312628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98954639T ATE253913T1 (de) | 1997-11-19 | 1998-11-19 | Anästhetikum |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5932597A (enExample) |
| EP (1) | EP1032390B1 (enExample) |
| JP (1) | JP2001522888A (enExample) |
| KR (1) | KR100695588B1 (enExample) |
| CN (1) | CN1131033C (enExample) |
| AT (1) | ATE253913T1 (enExample) |
| AU (1) | AU740914B2 (enExample) |
| BR (1) | BR9814883A (enExample) |
| CA (1) | CA2308495C (enExample) |
| DE (1) | DE69819770T2 (enExample) |
| DK (1) | DK1032390T3 (enExample) |
| ES (1) | ES2209217T3 (enExample) |
| HU (1) | HU228143B1 (enExample) |
| IL (1) | IL135922A0 (enExample) |
| NO (1) | NO328684B1 (enExample) |
| PT (1) | PT1032390E (enExample) |
| WO (1) | WO1999025349A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9824161D0 (en) * | 1998-11-04 | 1998-12-30 | Darwin Discovery Ltd | Drug formulation |
| US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| SI1575569T1 (sl) | 2002-12-13 | 2010-12-31 | Durect Corp | Oralni sistem dostave zdravila, ki obsega visokoviskozne tekoče nosilne materiale |
| SI2767292T1 (sl) | 2004-09-17 | 2017-01-31 | Durect Corporation | Pripravek, ki vsebuje lokalni anestetik SAIB, s podaljšanim sproščanjem |
| US20060270708A1 (en) * | 2005-05-25 | 2006-11-30 | Navinta Llc | Novel process for preparation of isotonic aqueous injection of ropivacaine |
| US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
| EP2117521B1 (en) | 2006-11-03 | 2012-06-27 | Durect Corporation | Transdermal delivery systems comprising bupivacaine |
| EP2067471B1 (en) * | 2007-12-06 | 2018-02-14 | Durect Corporation | Oral pharmaceutical dosage forms |
| US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
| SG11201407323WA (en) * | 2012-05-10 | 2014-12-30 | Cellix Bio Private Ltd | Compositions and methods for the treatment of local pain |
| CA2905131A1 (en) | 2013-03-15 | 2014-09-18 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| EP3331508B1 (en) * | 2015-07-13 | 2024-08-14 | Neon Laboratories Ltd. | Hyperbaric solution injection of levobupivacaine hydrochloride comprising levobupivacaine hydrochloride |
| JP7258561B2 (ja) | 2016-07-06 | 2023-04-17 | オリエント ファーマ シーオー．，エルティーディー． | 薬物組成物、バリヤー層及び薬物層を有している経口投与形態 |
| KR20220140711A (ko) | 2020-01-13 | 2022-10-18 | 듀렉트 코퍼레이션 | 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법 |
| KR20230145053A (ko) | 2021-01-12 | 2023-10-17 | 듀렉트 코퍼레이션 | 지속 방출 약물 전달 시스템 및 관련 방법 |
| WO2025175174A1 (en) * | 2024-02-14 | 2025-08-21 | The Children's Medical Center Corporation | 2'-6'-pipecoloxylidide as a sensory-selective anesthetic |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8802564D0 (sv) * | 1988-07-08 | 1988-07-08 | Astra Ab | New synergistic preparations and a new method of alleviation of pain |
| GB9321061D0 (en) * | 1993-10-13 | 1993-12-01 | Chiroscience Ltd | Analgestic agent and its use |
| EP0727210B1 (en) * | 1993-10-13 | 2001-12-19 | Darwin Discovery Limited | Analgesic agent and its use |
-
1998
- 1998-11-19 WO PCT/GB1998/003479 patent/WO1999025349A1/en not_active Ceased
- 1998-11-19 DE DE69819770T patent/DE69819770T2/de not_active Expired - Lifetime
- 1998-11-19 JP JP2000520782A patent/JP2001522888A/ja active Pending
- 1998-11-19 ES ES98954639T patent/ES2209217T3/es not_active Expired - Lifetime
- 1998-11-19 HU HU0004665A patent/HU228143B1/hu unknown
- 1998-11-19 DK DK98954639T patent/DK1032390T3/da active
- 1998-11-19 CN CN98811339A patent/CN1131033C/zh not_active Expired - Lifetime
- 1998-11-19 KR KR1020007005443A patent/KR100695588B1/ko not_active Expired - Lifetime
- 1998-11-19 US US09/195,908 patent/US5932597A/en not_active Expired - Lifetime
- 1998-11-19 AT AT98954639T patent/ATE253913T1/de active
- 1998-11-19 PT PT98954639T patent/PT1032390E/pt unknown
- 1998-11-19 EP EP98954639A patent/EP1032390B1/en not_active Expired - Lifetime
- 1998-11-19 IL IL13592298A patent/IL135922A0/xx not_active IP Right Cessation
- 1998-11-19 BR BR9814883-4A patent/BR9814883A/pt not_active Application Discontinuation
- 1998-11-19 AU AU11684/99A patent/AU740914B2/en not_active Expired
- 1998-11-19 CA CA002308495A patent/CA2308495C/en not_active Expired - Lifetime
-
2000
- 2000-05-18 NO NO20002545A patent/NO328684B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2308495C (en) | 2009-01-06 |
| AU1168499A (en) | 1999-06-07 |
| HUP0004665A2 (hu) | 2001-04-28 |
| WO1999025349A1 (en) | 1999-05-27 |
| CA2308495A1 (en) | 1999-05-27 |
| NO20002545L (no) | 2000-05-18 |
| KR20010032241A (ko) | 2001-04-16 |
| BR9814883A (pt) | 2000-10-03 |
| EP1032390B1 (en) | 2003-11-12 |
| AU740914B2 (en) | 2001-11-15 |
| JP2001522888A (ja) | 2001-11-20 |
| DK1032390T3 (da) | 2004-03-15 |
| DE69819770T2 (de) | 2004-09-23 |
| HK1026848A1 (en) | 2000-12-29 |
| DE69819770D1 (de) | 2003-12-18 |
| NO328684B1 (no) | 2010-04-26 |
| CN1279607A (zh) | 2001-01-10 |
| NO20002545D0 (no) | 2000-05-18 |
| PT1032390E (pt) | 2004-04-30 |
| KR100695588B1 (ko) | 2007-03-14 |
| EP1032390A1 (en) | 2000-09-06 |
| HUP0004665A3 (en) | 2004-05-28 |
| HU228143B1 (en) | 2012-12-28 |
| US5932597A (en) | 1999-08-03 |
| IL135922A0 (en) | 2001-05-20 |
| CN1131033C (zh) | 2003-12-17 |
| ES2209217T3 (es) | 2004-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE253913T1 (de) | Anästhetikum | |
| ATE367097T1 (de) | Verwendung von füllstoffe als sättigungsmittel | |
| BR0214184A (pt) | Composições que contêm óleos que possuem gravidade especìfica mais alta que a gravidade especìfica da água | |
| BR0207420A (pt) | Processo e composições para desinfecção de superfìcies duras | |
| AU2003298179A1 (en) | Lens care composition and method | |
| ATE181465T1 (de) | Rahmengestell aus rahmenschenkeln und tiefenstreben | |
| DK1068870T3 (da) | Antitumormidler | |
| NO20033546D0 (no) | 4-fluor-N-indan-2-yl-benzamid og dets anvendelse som legemiddel | |
| AR002932A1 (es) | Solucion acuosa de interferon | |
| ATE359823T1 (de) | Zusammensetzung, welche ein antifolate und ein methylmalonsäuresenkendes mittel enthält | |
| EE03235B1 (et) | Emulsioonvorm, selle valmistamise protsess ja kasutamine | |
| JP2001522888A5 (enExample) | ||
| HUP0203773A2 (hu) | Epinastintartalmú oldatok | |
| DE60104872D1 (de) | Stabilisierte ophthalmische wasserstoffperoxidlösung | |
| DK0460062T3 (da) | Huperzin A-analoger | |
| RU2004102395A (ru) | Жидкая композиция, включающая сложный эфир полиоксиэтиленсорбита и жирной кислоты | |
| DK0666739T3 (da) | Intravenøs opløsning som formindsker protein- og vandtab fra kroppen | |
| EA200200502A1 (ru) | Способ введения ингибитора фосфодиэстеразы 4 | |
| ATE238803T1 (de) | Pphospholipidkomplexe von proanthocyanidin a2 als antiatherosklerotische mittel | |
| ES2137352T3 (es) | Composiciones oftalmicas que incluyen emedastina y su utilizacion para tratar conjuntivitis alergicas. | |
| EP1420743A4 (en) | CHOLESTEROL SULFATE AND AMINO SUGAR COMPOSITIONS FOR IMPROVING THE FUNCTION OF THE CORNEO LAYER OF EPIDERMA | |
| DE3875349D1 (de) | Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie. | |
| DE69320352D1 (de) | Piperidinylamide, sulfonamide und sulfoxamide als inhibitoren der cholesterin biosynthese | |
| CO5580773A2 (es) | Rosuvastatina en estados pre dementes | |
| ATE333877T1 (de) | Amlopidinbezylat-tabletten mit verbesserter stabilität |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1032390 Country of ref document: EP |